June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Characterization of two-year occurrence of subclinical macular edema in different risk phenotypes of diabetic retinopathy
Author Affiliations & Notes
  • Torcato Santos
    AIBILI – Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
  • Ines Pereira Marques
    AIBILI – Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Maria Luísa Ribeiro
    AIBILI – Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Sónia Ferreira
    AIBILI – Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
  • Ana Rita Santos
    AIBILI – Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Jose G Cunha-Vaz
    AIBILI – Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Footnotes
    Commercial Relationships   Torcato Santos EPO 3 289 565 B1, USPTO 15/568,161, Code P (Patent); Ines Marques None; Maria Luísa Ribeiro None; Sónia Ferreira None; Ana Rita Santos None; Jose Cunha-Vaz Carl Zeiss Meditec, Ciana Therapeutics, Allergan, Bayer, Roche, Adverum Biotechnologies, NovaGo Therapeutics, Emerton, Code C (Consultant/Contractor), EPO 3 289 565 B1, USPTO 15/568,161, Code P (Patent)
  • Footnotes
    Support  PTDC/MEC-OFT/30375/2017
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3363 – F0172. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Torcato Santos, Ines Pereira Marques, Maria Luísa Ribeiro, Sónia Ferreira, Ana Rita Santos, Jose G Cunha-Vaz; Characterization of two-year occurrence of subclinical macular edema in different risk phenotypes of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3363 – F0172.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To characterize the two-year occurrence of macular edema of different diabetic retinopathy phenotypes in type 2 diabetes (T2D) focusing in changes in central retinal thickness (CRT).

Methods : A prospective longitudinal cohort study (CORDIS, NCT03696810) was conducted with 3 visits (baseline, 6-months and two-year). Demographic and systemic data included age, sex, diabetes duration, lipidic profile and hemoglobin A1c (HbA1c). Ophthalmological examinations included visual acuity, color fundus photography (CFP) and optical coherence tomography (OCT and OCTA), identified the presence of nonproliferative diabetic retinopathy. Phenotype classification was performed, at 6-month visit, based on microaneurysm turnover (MAT, on CFP) and CRT (on OCT). Only risk phenotypes B (MAT<6 and increased CRT) and Phenotype C (MAT≥6 with or without increased CRT) were included. ETDRS grading was performed at the baseline and last visits based on 7-fields CFP. OCT data was analyzed with OCT-Leakage, a novel technique for noninvasive assessment of abnormal accumulation of fluids in the retina through low optical reflectivity ratios (LOR).

Results : Of the 133 T2D individuals included in the study, 81 eyes (60%) were classified as phenotype B and 52 (40%) eyes as phenotype C. Of these 127 completed the two-year follow-up, with 24 (19%) developing central-involved macular edema (CIME) and 2 (1.6%) clinically significant macular edema.
Patients that developed CIME showed an increase in CRT with time when compared to patients that did not (ß=10.318, p<0.001). This difference remains statistically significant when controlling for age, sex, diabetes duration and HbA1c.
Changes in time for CRT, over the two-year period of follow-up, are positively associated with longitudinal changes in LOR ratios (ß=53.113, p<0.001) and with longitudinal changes in vessel density (increase) in the deep capillary plexus (ß=0.811, p<0.001) and superficial capillary plexus (ß=1.516, p<0.002). Patients with different ETDRS levels have similar alterations across visits for CRT, as well as for both phenotypes, B and C.

Conclusions : In the two-year period of follow-up CRT changes followed similar response patterns for both phenotypes and different ETDRS levels. CRT changes showed a clear association with the development of CIME.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Longitudinal associations between changes across visits in CRT and other variables of interest

Longitudinal associations between changes across visits in CRT and other variables of interest

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×